Myopia (nearsightedness) is not just a need for glasses. It is a progressive eye condition that can increase the lifetime risk of serious vision-threatening diseases—especially when it begins in childhood and progresses rapidly.

At Shekhar Eye Research, we emphasize that myopia is not merely a refractive error—it is an ocular health condition that requires monitoring and management.

In myopia, the eye becomes longer (axial elongation) than normal.
This stretching:

• Thins the retina
• Weakens supporting eye structures
• Increases vulnerability to degenerative changes

The higher the myopia, the greater the risk.

As the eye elongates, the retina stretches and becomes fragile.
This increases the risk of:

• Retinal tears
• Retinal holes
• Retinal detachment

Retinal detachment is a medical emergency and may cause permanent vision loss if untreated.

High myopia can cause degenerative changes in the macula, leading to:

• Central vision distortion
• Blurred vision
• Permanent central vision loss

This condition is progressive and difficult to reverse.

Myopic patients have a higher risk of developing glaucoma due to:

• Structural optic nerve vulnerability
• Thinner scleral support
• Altered biomechanics of the eye

Early detection is critical.

Studies show that myopic individuals may develop certain types of cataracts earlier than non-myopes.

Lattice degeneration and peripheral retinal thinning are more common in myopic eyes.

When myopia starts early:

• It progresses faster
• Axial length increases more
• Final adult prescription becomes higher

Every additional diopter of myopia increases lifetime risk of ocular complications.

That is why early intervention is essential.

Myopia LevelRisk of Retinal DiseaseMild (-1.00 to -3.00 D)Slightly elevatedModerate (-3.00 to -6.00 D)Significantly higherHigh Myopia (-6.00 D and above)Very high lifetime risk

Even moderate myopia increases risk compared to non-myopic eyes.

• Excessive near work
• Screen overuse
• Limited outdoor time
• Genetic predisposition
• Poor visual hygiene

Children today are particularly vulnerable due to digital lifestyles.

At Shekhar Eye Research, we focus on:

• Slowing axial elongation
• Reducing progression rate
• Protecting long-term retinal health
• Preventing high myopia

Modern strategies include:

• Orthokeratology
• Specialty myopia control lenses
• Red Light Therapy protocols
• Lifestyle modification
• Axial length monitoring

Glasses correct vision.
They do not stop progression.

Scientific myopia control strategies can reduce progression by 40–70% when started early.

We do not just prescribe glasses.
We monitor, measure, and manage.

Every child with myopia deserves:

• Axial length tracking
• Risk assessment
• Personalized control plan
• Regular monitoring

Clear vision today is important.
Healthy eyes for life are essential.

If your child’s number is increasing every year, it is time to move beyond regular glasses.

Book a Myopia Risk Evaluation at Shekhar Eye Research.
Because preventing high myopia today protects vision tomorrow.

Myopia (nearsightedness) is increasing globally at an alarming rate. It is not just a glasses problem — it is a progressive eye growth disorder that can increase lifetime risk of retinal detachment, glaucoma, and myopic maculopathy.

At Shekhar Eye Research, we do not simply prescribe stronger glasses each year.
We actively measure, monitor, and control myopia progression using evidence-based, internationally accepted strategies.

Our approach is structured, customized, and scientifically monitored.

Every child undergoes:

• Detailed refractive evaluation
• Corneal topography (when required)
• Axial length measurement
• Binocular vision assessment
• Lifestyle risk analysis
• Personalized treatment planning

We select the most suitable strategy — or combination — depending on age, progression rate, lifestyle, and ocular parameters.

Orthokeratology uses custom-designed overnight lenses to gently reshape the cornea while the child sleeps.

Benefits:

• Clear daytime vision without glasses
• Reduces axial elongation
• Ideal for active children and sports enthusiasts
• Reversible and non-surgical

We use FDA-approved high oxygen-permeable materials, and all lenses are custom designed for individual eyes and manufactured in the USA to ensure precision and safety.

Ortho-K is one of the most effective myopia control methods when properly fitted and monitored.

Modern defocus spectacle lenses are specially engineered to:

• Provide clear central vision
• Create peripheral myopic defocus
• Slow eye growth

Unlike regular single-vision glasses (which only correct blur), defocus lenses actively work to reduce progression.

These are ideal for:

• Younger children
• Children not ready for contact lenses
• Moderate progressors

Low-dose atropine eye drops are clinically proven to slow myopia progression.

Mechanism:

• Modulates eye growth signals
• Reduces axial elongation

Benefits:

• Easy nightly instillation
• Minimal effect on pupil size at low concentrations
• Can be combined with optical methods

We use carefully titrated protocols and monitor response regularly to ensure safety and effectiveness.

Environmental and behavioral factors play a major role in myopia progression.

We emphasize:

• Minimum 90–120 minutes of outdoor activity daily
• Controlled screen time
• Proper reading distance
• Adequate lighting
• Frequent visual breaks (20-20-20 rule)

Lifestyle modification enhances the effectiveness of all other treatment methods.

Red Light Therapy is an emerging technology in myopia management.

It works by:

• Stimulating retinal biochemical pathways
• Influencing scleral remodeling
• Reducing axial elongation

At Shekhar Eye Research, we offer structured protocols using scientifically validated systems.

RLT can be used:

• As standalone therapy
• In combination with optical methods
• In rapidly progressing cases

Careful supervision and follow-up are mandatory for safety and effectiveness.

Many children benefit from combination treatment, such as:

• Orthokeratology + Low-dose Atropine
• Defocus Glasses + Atropine
• Optical methods + Red Light Therapy
• All strategies supported by lifestyle modification

Treatment is never “one size fits all.”
It is customized based on measurable progression.

• Decades of expertise in specialty contact lenses and myopia science
• Advanced axial length monitoring
• Personalized evidence-based protocols
• FDA-approved materials and high-quality manufacturing
• International standard of care

We focus on long-term eye health, not just short-term clarity.

Stronger glasses every year is not a solution.
Controlling eye growth is.

The earlier we start, the better the outcome.

If your child’s prescription is increasing annually, it is time for scientific intervention.

Book a Comprehensive Myopia Control Evaluation at Shekhar Eye Research.

Because preventing high myopia today protects vision for a lifetime.

At Shekhar Eye Research, we believe every child’s eye is unique — and so is their myopia progression pattern.

That is why we developed the MyoKiddo™ Myopia Control Program — a structured, risk-based, technology-driven system that combines:

• MyoKiddo DF (Defocus) Glasses
• MyoKiddo RED Light Therapy (RLT)
• Individualized Risk-Based Myopia Management

Our goal is simple:
Slow eye growth. Reduce long-term risk. Protect lifetime vision.

MyoKiddo DF glasses are specially designed myopia control spectacle lenses that do more than correct blur.

Unlike regular single-vision glasses, these lenses:

• Provide clear central vision
• Create controlled peripheral myopic defocus
• Send signals to reduce axial elongation
• Help slow progression of myopia

✔ Customized prescription optimization
✔ Designed for Indian pediatric facial parameters
✔ Lightweight, child-friendly frames
✔ Scientifically structured fitting protocol
✔ Regular monitoring of progression

These lenses are ideal for:

• Young children
• Early myopes
• Children not ready for contact lenses
• Mild to moderate progressors

They are comfortable, safe, and easy to adapt to — making them an excellent first-line intervention.

MyoKiddo RED Light Therapy is a non-invasive, scientifically structured therapy designed to influence eye growth at a biochemical level.

• Delivers specific wavelength red light
• Stimulates retinal signaling pathways
• Modulates scleral remodeling
• Reduces axial elongation

✔ Short treatment sessions
✔ Non-surgical
✔ Child-friendly design
✔ Can be combined with optical methods
✔ Suitable for fast progressors

Red Light Therapy is particularly useful for:

• Rapidly progressing myopes
• Children with strong genetic risk
• Cases not adequately controlled by glasses alone
• Combination therapy protocols

At Shekhar Eye Research, RLT is delivered under strict supervision with structured follow-up and axial length monitoring.

Not all myopia progresses at the same rate.

At Shekhar Eye Research, we use a Risk-Based Myopia Management Model.

We evaluate:

• Age of onset
• Family history
• Baseline refractive error
• Axial length measurement
• Rate of progression
• Lifestyle factors
• Screen exposure
• Outdoor activity

Based on this, we categorize children into:

Lifestyle modification + DF Glasses

DF Glasses + Atropine / Optical therapy

Combination therapy (DF Glasses / Ortho-K + RLT + Atropine)

Aggressive combination therapy with close axial length monitoring

Myopia is not just about spectacle number.
It is about eye growth (axial length).

We monitor:

• Baseline axial length
• Growth trend every 6 months
• Treatment response
• Long-term stabilization

This ensures data-driven decisions — not guesswork.

• Structured scientific protocol
• Personalized treatment selection
• Combination therapy when required
• Advanced monitoring technology
• Decades of expertise in myopia science
• Long-term safety-focused approach

We treat the child, not just the prescription.

Stronger glasses every year is not management.
Understanding risk and controlling progression is.

Early intervention reduces the chance of:

• High myopia
• Retinal complications
• Glaucoma risk
• Myopic maculopathy

If your child’s number is increasing every year, do not wait.

Start early.
Monitor scientifically.
Control progression intelligently.

Enroll in the MyoKiddo™ Myopia Control Program at Shekhar Eye Research today.

Because healthy eyes today mean safer vision tomorrow.